These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4942504)

  • 1. [Antidiabetic biguanides in the prevention of fatty liver induced by high-fat diet in rabbits. Histopathologic examination].
    Agid R; Amiel S; Guilhem A; Marquié G
    Pathol Biol (Paris); 1971; 19(15):727-33. PubMed ID: 4942504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention, by antidiabetic biguanides, of hepatic cholesteatosis induced by cholesterol in the rabbit. Histopathological examination].
    Marquié G; Agid R; Amiel S; Guilhem A
    C R Seances Soc Biol Fil; 1970; 164(3):648-54. PubMed ID: 4250425
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive effects of NN-dimethylbiguanide on hepatic steatosis of nutritional origin in rabbits].
    Marquié G; Agid R
    J Physiol (Paris); 1971; 63(2):75A. PubMed ID: 5561564
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive effects of pioglitazone on rat fatty liver induced by a high fat diet].
    Xu P; Li YM; Yu CH; Xu L; Xu GY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):701-2. PubMed ID: 16995993
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the mechanism of action of phenethylbiguanide (PEBG). II. Effect on spontaneous and glucagon-induced hepatic glycogenolysis in vitro].
    Fratino P; Rodari T; Maggi G
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1881-3. PubMed ID: 5628805
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic and antioxidative changes in liver steatosis induced by high-fat, low-carbohydrate diet in rabbits.
    Birkner E; Kasperczyk S; Kasperczyk A; Zalejska-Fiolka J; Zwirska-Korczala K; Stawiarska-Pieta B; Grucka-Mamczar E
    J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():45-58. PubMed ID: 16340038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T; Miura K; Kajioka T; Kitahara Y
    Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet.
    Sene-Fiorese M; Duarte FO; Scarmagnani FR; Cheik NC; Manzoni MS; Nonaka KO; Rossi EA; de Oliveira Duarte AC; Dâmaso AR
    Obesity (Silver Spring); 2008 Oct; 16(10):2217-22. PubMed ID: 18719640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC).
    Gilat T; Leikin-Frenkel A; Goldiner I; Juhel C; Lafont H; Gobbi D; Konikoff FM
    Hepatology; 2003 Aug; 38(2):436-42. PubMed ID: 12883488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effects of an antidiabetic biguanide, NN'-dimethylbiguanide, on the lipid disturbances induced by the administration of cholesterol in rabbits].
    Marquié G; Agid R
    C R Acad Hebd Seances Acad Sci D; 1968 Jun; 266(26):2465-8. PubMed ID: 4971298
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of antidiabetic biguanides on various types of lipid mobilization in the rabbit].
    Marquié G; Agid R
    J Physiol (Paris); 1973 Sep; 66(3):345-56. PubMed ID: 4788518
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the mechanism of action of phenethylbiguanide (PEBG). IV. Effect on adrenalin-induced hyperglycemia in normal animals].
    Fratino P; Maggi G; Rodari T
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1886-8. PubMed ID: 5601974
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the mechanism of action of phenethylbiguanide (PEBG). 3. Effects on glucagon-induced hyperglycemia in vivo].
    Fratino P; Maggi G; Rodari T
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1883-6. PubMed ID: 5601973
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of oral hypoglycemic agents on the fatty acid composition of liver and depot lipids in rats].
    Bernhard K; Spreng E
    Z Klin Chem Klin Biochem; 1971 May; 9(3):242-4. PubMed ID: 5153836
    [No Abstract]   [Full Text] [Related]  

  • 16. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents.
    Leikin-Frenkel A; Goldiner I; Leikin-Gobbi D; Rosenberg R; Bonen H; Litvak A; Bernheim J; Konikoff FM; Gilat T
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1205-13. PubMed ID: 18989145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current views on the mode of action of blood glucose lowering biguanides].
    Segre G
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():627-35. PubMed ID: 4984396
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
    Kuzu N; Bahcecioglu IH; Dagli AF; Ozercan IH; Ustündag B; Sahin K
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e465-70. PubMed ID: 17683497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
    Pan M; Song YL; Xu JM; Gan HZ
    J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.